The optimal therapy for acute bronchitis depends on the causative pathogen
and the presence or absence of underlying lung disease. Because there is no
fast, reliable way to identify the pathogen, physicians have to rely on cl
inical judgment and epidemiologic characteristics. In this article, Drs Fla
herty, Saint, Fendrick, and Martinet discuss how an evidence-based approach
to treatment may help ensure that efficacious therapy is available in the
future.